Search

Author/Creator Furst, D

1. OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial). (1st June 2001)

Authors:
Keystone, E; Weinblatt, ME; Weisman, M; Furst, D; Paulus, H; Birbara, C; Fischkoff, S; Chartash, EK
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Issue 8 (27th January 2005)

Authors:
Dervieux, T; Furst, D; Lein, D O; Capps, R; Smith, K; Caldwell, J; Kremer, J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 64:Issue 8(2005)
Page Start:
1180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Issue 6 (1st June 2001)

Authors:
Binks, M; Passweg, J R; Furst, D; McSweeney, P; Sullivan, K; Besenthal, C; Finke, J; Peter, H H; van Laar, J; Breedveld, F C; Fibbe, W E; Farge, D; Gluckman, E; Locatelli, F; Martini, A; van den Hoogen, F; van de Putte, L; Schattenberg, A V N; Arnold, R; Bacon, P A
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60:Issue 6(2001)
Page Start:
577
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. THU0695 The RA FLARE questionnaire (RA-FQ) is responsive to change in ra symptoms and impacts in clinical and observational trials. (15th June 2017)

Authors:
Bartlett, SJ; Bykerk, VP; Fautrel, B; Guillemin, F; Broeder, A den; Alten, R; Christensen, R; Choy, E; Furst, D; Hewlett, S; Leong, A; March, L; Woodworth, T; Clifton, BIO
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
470
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). (1st June 2001)

Authors:
Schiff, M; Furst, D; Fleischmann, R; Macri, M; Joh, T; Edwards, CK; Davis, MW
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. SAT0132 The rheumatoid arthritis flare questionnaire (RA-FQ): results of rasch analysis and feedback on real-world applications from international RA patients and clinicians. (15th June 2017)

Authors:
Bartlett, SJ; Barbic, SP; Bykerk, VP; Fautrel, B; Guillemin, F; Broeder, A den; Alten, R; Christensen, R; Choy, E; Furst, D; Hewlett, S; Leong, A; March, L; Woodworth, T; Clifton, BIO
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
818
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. (15th June 2017)

Authors:
Volkmann, ER; Sim, M; Tashkin, DP; Khanna, D; Clements, PJ; Roth, M; Furst, D; Pickney, A; Goldmuntz, E; Keyes-Elstein, L; Elashoff, R; Sullivan, K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗